Oncotarget interview: "TRAIL receptor agonists convert the response of #breastcancer cells to ONC201 from anti-proliferative to apoptotic." https://youtu.be/nyw1AQl72O4 #eldeirylab
Pathology and Laboratory Medicine
Date
July 9, 2021
Oncotarget Interview with Dr. Wafik El-Deiry
A new Oncotarget interview with Dr. El-Deiry and a former MD/PhD student in his lab on the paper